The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

From fashionable flashbacks to a retro inspired court, to a fresh new partner, over the next two seasons, the Grizzlies will ...

Jazz Pharma's diversified drug portfolio drives revenue growth. Zanidatamab shows promise with potential FDA approval in late ...

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), ...

"We are grateful to the FDA for their collaboration and review of our complete response package, which included a comprehensive safety assessment of the azenosertib program,” said Kimberly Blackwell, ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for ...

Gautam Adani and the Adani Group withdraw from acquiring Gujarat Titans IPL franchise, paving the way for Torrent Group to ...

Dr Sam White claimed that the virus was planned and orchestrated by pharmaceutical companies along with tech tycoons Bill ...

Advt The Jan Aushadhi initiative aims to enhance access to cost-effective, unbranded generics by scaling up to 25,000 franchise pharmacies by 2026, it said. "It is estimated that Jan Aushadhi ...

Mankind Pharma Ltd is set to raise over Rs 9,000 crore through a mix of non-convertible debentures (NCDs) and short-term commercial paper. This financing is intended to support its Rs 13,630 crore ...

Recursion Pharmaceuticals Inc RXRX shares are trading lower. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).